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Abstract: Metallothioneins (MTs) are cysteine-rich proteins, which have been implicated in regulation of physiological 
processes, such as cell growth, repair, differentiation, apoptosis and immunoregulation, as well as in the protection against heavy 
metals, oxidant damages, inflammation and other stressful conditions. To investigate their roles in physiological and 
detoxification processes at the maternal-fetal interface and in fetal organogenesis we examined the tissue expression of MT I/II 
isoforms in undisturbed syngeneic pregnancy and after the treatment with peptidoglycan monomer linked with zinc (PGM-Zn). 
The data showed that in undisturbed pregnancy the MTs were highly expressed at junctional zone of placenta, on endovascular 
trophoblast giant cells, glycogen cells and spongiotrophoblast cells, as well as on villous trophoblast cells. In the fetus they were 
found predominantly in the liver and in epithelial tissues, such as intestine, pancreas and kidney. Treatment with PGM-Zn 
markedly enhanced the intensity of MT staining both at the maternal-fetal interface and in fetal organs. The data imply that MTs 
are involved in the protection of trophoblast cells against the pregnancy-induced deregulation of redox and 
neuro-immuno-endocrine homeostasis, in transport and storage of essential metals required for fetal organogenesis, as well as in 
the protection of fetus against bacterial toxins. 




The embryonic and fetal development in the maternal 
uterine environment requires the establishment of delicate 
equilibrium between the mother and the fetus, which at the 
feto-maternal interface ensures the blastocyst adhesion, 
trophoblast differentiation and decidualization, angiogenesis 
and vascular remodelling that enables maternal-fetal exchange 
of nutrients, and development of the embryo. The processes 
are highly dependent on the activation of molecular pathways 
that regulate the differentiation and functions of various 
trophoblast and adjacent cell subtypes that fuse into a 
syncytium to increase the surface area for nutrient transport 
and maternal blood flow (for reviews see [1-4]. Moreover, for 
the success of pregnancy it is important that the specific 
mechanisms create at the maternal-fetal interface a condition 
of local immunological tolerance, which ensures that the 
semi-allogeneic fetus is not rejected by the maternal immune 
system [5-8]. Any disturbance of physiological and 
immunological equilibrium established between the mother 
and the fetus may contribute to the development of pathologic 
conditions of pregnancy, such as preeclampsia, spontaneous 
miscarriage and fetal growth restriction. 
A number of evidence shows that in these events important 
roles may have also metallothioneins (MTs) [9-13], which are 
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phylogenetically conserved proteins involved in a broad 
spectrum of crucial biologic functions related with the 
proliferation, differentiation, apoptosis and immunoregulation 
[14-20]. Namely, owing to their potent metal-binding and 
redox capabilities they promptly react on zinc and copper 
dyshomeostasis, on changes in oxidoreductive cellular 
metabolism and hormonal status, as well as on environmental 
toxins, proinflammatory signals and oxidative or nitrative 
stress that may appear in maternal uterine environment and 
during the fetal growth. The role of MTs in pregnancy have 
been early recognized [11-13, 21, 22], but the interest for the 
functions of MT/zinc network in pregnancy are renewed, 
owing to recent evidence that various epigenetic mechanisms 
might have high influence on pregnancy outcome and on 
development of pregnancy-associated diseases [23-26].  
To address some aspects of this issue, in the present study 
we investigated the expression of MT I/II at the feto-maternal 
interface and in the fetal organs in late murine pregnancy. To 
restrict the investigations on physiological processes involved 
in the maintenance of normalcy and integrity of tissue 
architecture and to compare the data with our previously 
reported findings about the functions of heat shock protein - 
gp96 at this place [27], all experiments in this study were 
performed in the syngeneic pregnancy. The data clearly 
showed that at that time the MT I/II were highly upregulated 
both at the maternal-fetal interface and in fetal tissues, as well 
as that the exposure of pregnant mice to PGM-Zn, originally 
derived from Gram + bacteria, might enhance the expression 
of these metalloproteins.  
2. Material and Methods 
2.1. Mice 
Experiments were done on pregnant C57BL/6 mice, mated 
with syngeneic partner, at the age of 2–4 months, as we 
previously described [27]. Day of detection of vaginal plug 
was considered day 0 of gestation. All mice were provided by 
Animal Cure facility of Medical School, Rijeka, whose ethical 
committee has approved the all experiments. 
2.2. Treatment with Peptidoglycan Monomer Linked with 
Zinc (PGM-Zn) 
Pregnant mice were treated with PGM-Zn (Pliva, Zagreb, 
Croatia) dissolved in phosphate-buffered saline (PBS), as we 
previously described [27, 28]. Peptidoglycan monomer (PGM; 
Pliva, Zagreb, Croatia) 
(GlcNAc-MurNAc-L-Ala-D-iso-Glnmesodiamminopimelic 
acid (w-NH2)-D-Ala-D-Ala) was prepared from 
peptidoglycan of Brevibacterium divaricatum NRRL-2311, as 
an apyrogenic, water-soluble substance devoid of any toxic 
effects [29]. Treatment started on day 0 of gestation and lasted 
6 days (10 mg/kg intraperitoneally (i.p.) every 48h). In the 
control group mice were identically treated with PBS. 
Pregnant females were sacrified on the 16th gestational day 
(gd) of syngeneic pregnancy.  
2.3. Tissue Preparation 
Placenta and fetal tissues were rapidly removed, fixed in 
10 % buffered formalin solution for 24h and embedded in 
paraffin wax. Sections were cut at 4 µm using HM 340E 
microtome (Germany). Heat induced epitope retrival was 
done prior to staining procedures by heating tissue slides in 
boiled citrate buffer pH 6.0 four times, each 5 minutes, using a 
microwave steamer. 
2.4. Immunohistochemistry 
Immunohistochemistry was performed on formalin-fixed 
paraffin-embedded tissues, after heat induced epitope retrieval, 
using the DAKO EnVision+System, Peroxidase (DAB) kit 
(DAKO Corporation, USA), as previously described [30]. 
Endogenous peroxidase activity was eliminated with 
peroxidase block. MT I+II antigens were detected by 
monoclonal anti-MT I+II antibody (clone E9; 
DakoCytomation, USA), diluted 1:50 in phosphate-buffered 
saline supplemented with bovine serum albumin. Tissue 
samples were incubated overnight at 4 °C in a humid 
environment, followed by 45 minutes incubation with 
peroxidase labeled polymer conjugated to goat anti-mouse 
immunoglobulins containing carrier protein linked to Fc 
fragments to prevent nonspecific binding. The 
immunoreaction product was visualized by adding 
substrate-chromogen (DAB) solution. Tissues were 
counterstained with hematoxylin and 37 mM ammonia water, 
dehydrated in gradient of alcohol, and mounted with mounting 
medium. The specificity of the reaction was confirmed by 
substitution of antigen-specific antibody with mouse 
irrelevant IgG1 kappa immunoglobulin (clone DAK-G01; 
Dako, USA), used in the same conditions and dilutions as a 
primary antibody. The slides were examined on an Olympus 
BX51 photomicroscope (Olympus, Tokyo, Japan). 
3. Results 
3.1. Expression of MT I/II at Maternal-Fetal Interface in 
Undisturbed Pregnancy and After the Treatment with 
PGM-Zn 
As shown on Fig. 1A, in gravid uterus (at the 16th gd) a 
marked upregulation of MT I/II expression was found both on 
the extravillous and villous trophoblasts, affecting particularly 
the junctional zone of placenta, consisting of 
spongiotrophoblast cells (STC) and a layer of trophoblast 
giant cells (TGC) that line the implantation site (Fig. 1A d-f). 
MT expression was found also in the branched labyrinthine 
layer (g-i) on vascular endothelium (i), glycogen trophoblast 
cells (GTCs) and on monocytes-like cells (i), as well as in the 
villous cytotrophoblast (CT) (-l). MT staining was 
predominantly cytoplasmic, but in some spongiotrophoblast 
cells (e, f) and in GTCs (i) the nuclear staining was also seen. 
Besides, a fine MT staining was found in polyploid nuclei of 
TGC, characterized by extremely large cytoplasm (Fig. 1Af, 
arrow). Treatment with PGM-Zn highly upregulated the 
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immunostaining of MT I/II on various trophoblast cell 
subtypes in junctional zone of placenta (Fig. 1B a-c). High 
cytoplasmic MT expression was found also on several villous 
CT cells (Fig. 1B e, f). 
 
Figure 1. Expression of MT I/II at the feto-maternal interface on the 16th 
gestational day of syngeneic pregnancy in undisturbed (A) and PGM-Zn 
treated mice (B). Paraffin-embedded tissue sections (4 µm) were 
immunostained with monoclonal anti-MT I+II antibody (clone E9; 
DakoCytomation, USA) (A d-i and B a-f) or with mouse irrelevant IgG1 kappa 
immunoglobulin (clone DAK-G01; Dako, USA) (a-c). The results are 
representative findings of 3 mice. Magnification in first, second and third 
column is 100x, 400x and 1000x, respectively.  
3.2. Expression of MT I/II in Fetuses of Undisturbed and 
PGM-Zn Treated Mothers  
High MT expression was observed in several fetal organs, 
removed from untreated and PGM-Zn treated mothers (Fig. 2). 
The highest immunostaining was noticed in fetal liver (Fig. 2a, 
e-g), where a clear distinction was observed between the MT 
positive layers of hepatoblasts and the MT negative foci of 
hematopoetic cells (Fig. 2 e-g). High MT immunopositivity 
was found also on liver sinusoidal endothelial cells (LSEC) 
and stromal cells (Fig. 2 g). In pancreas MTs were expressed 
particularly on exocrine parts of the gland (Fig. 2 i-k). A high 
cytoplasmic MT immunostaining was found also in intestinal 
villi in columnar epithelial cells and on granular secretory 
Paneth cells (Fig. 2 m-o). In the fetal kidney upregulation of 
MTs was observed in the cortical area on tubules near to the 
glomeruli (Fig. 2 r), suggesting that they were proximal or 
distal tubules, but the involvement of collecting ducts in renal 
medulla cannot be excluded (Fig. 2t). High expression of MTs 
was observed also in the fetal skin, particularly on developing 
hair folicules (not shown). Treatment with PGM-Zn 
upregulated the expression of MT I/II at all described 
locations, increasing the immunostaining of this protein in 
hepatoblasts (Fig. 2 h), in pancreatic acini (i), in intestnal villi 
(p ), as well as in the kidney (u).  
 
Figure 2. Expression of MT I/II in the fetuses, removed on the 16th gestational 
day from undisturbed mothers and mothers treated with PGM-Zn. 
Paraffin-embedded tissue sections (4 µm) were immunostained with 
monoclonal anti-MT I+II antibody (clone E9; DakoCytomation, USA) or with 
mouse irrelevant IgG1 kappa immunoglobulin (clone DAK-G01; Dako, USA) 
(b-liver; c-intestine; d-kidney). Magnification first column 40, second 
columns 400x, third and fourth columns 1000x. The results are representative 
findings of 3 fetuses. 
4. Discussion 
The data are in high agreement with previously published 
evidence showing that MTs, as phylogenetically ancient 
proteins [20], might participate in diverse processes that 
during pregnancy ensure the trophoblast differentiation and 
decidualization and enable the development of fetus [12, 13, 
31, 32]. Their role in pregnancy and fetal development has 
been recognized early after discovery of MTs in 1957 [33], but 
their pathogenetic mechanisms are still debated.  
Generally, type I and II isoforms of MT are constitutively 
expressed in nearly all organs in mammals. Their transcription 
may be upregulated in response to different stimuli, 
particularly heavy metals, glucocorticoids, oxidative stress 
and cytokines, which in metallothionein promoter region lead 
to activation of MT promoter response elements, termed metal 
response elements (MRE), glucocorticoid response elements 
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(GREs), elements activated by STAT (signal transducers and 
activators of transcription) proteins and by antioxidant 
response elements (AREs) [19, 34]. Besides, current evidence 
shows that expression of MTs is regulated also by epigenetic 
mechanisms, such as DNA methylation, histone modifications, 
and changes in levels of micro-RNAs that affect the 
inheritance of gene activities without changes in DNA base 
sequences, resulting in gene silencing or downregulation [19, 
34]. Importantly, MT transcription may be affected by 
environmental contaminations with heavy metals (nickel, 
cadmium, lead, aluminum, mercury, and arsenic) [35, 36], by 
diet, exposure to sun and etc (reviewed [37] i.e. by conditions 
that have high impact also on the pregnancy outcome. 
Noteworthy, recent evidence shows that normal pregnancy 
compared with non-pregnancy is a hypomethylated state that 
allows better maternal adaptation to the fetus [23], as well as 
that in distrubed pregnancies a widespread trend toward 
hypermethylation or hypomethylation of multiple genes in 
placenta might be found [38]. The latter include also the 
influences of prenatal and early postnatal nutrition [26], 
maternal smoking [39, 40] and exposure of mother to various 
toxic substances during the pregnancy [41-43]. Consistent 
with these proposals, recently it was found that Zn deficiency 
in utero might induce fetal epigenetic alterations of mouse 
metallothionein-2 gene and that these changes might be stored 
as an epigenetic memory until adulthood [26]. 
Our data, showing a high expression of MT I/II at the 
feto-maternal interface in the syngeneic pregnancy (Fig. 1A) 
emphasize that MT I/II isoforms are a part of physiological 
processes that are essential for successful placentation and fetal 
development. Since, this was observed in syngeneic pregnancy 
we can speculate that the activation of metallothionein/Zn 
network was related primarily with the pregnancy-induced 
dysregulation of redox and neuro-immuno-endocrine 
homeostasis. In this sense, MT transcription might be locally 
induced by syncytiotrophoblastic oxidative or nitrosative stress, 
created during the early phase of vascular remodelling, when 
endovascular trophoblast cells migrate into the lumens of spiral 
arteries to establish the maternal intervillous circulation [44-46], 
as well as by different cytokines secreted from uterine natural 
killer (uNK) and other cells at the feto-maternal interface [2, 3, 
47-49]. Additional influence might have local hormones 
involved in the process of placentation [50, 51], and various 
pathogen associated [52] or damage-associated molecular 
patterns [27, 53, 54]. Besides, since the mouse embryo develops 
the capacity to respond to metals in the environmental milieu at 
the third cleavage [55], there is a possibility that MTs were 
induced by metal transcription factor (MTF-1), functioning as a 
metalloregulatory transcription factor that activates 
metallothionein genes in response to the essential metal zinc [56] 
and regulates the cell-specific MT-I expression in visceral 
endoderm cells [57]. The hypothesis is supported by evidence 
showing that MTs, as cysteine-rich proteins with many 
intramolecular SH groups participate in maintenance of Zn and 
Cu homeostasis and heavy metal detoxication, as well as in 
scavenging of oxygen (ROS) and nitric oxide (NOS) species 
that appear during oxidative damages of DNA, proteins, and 
lipid membrane structures [14-19]. Besides, it should be taken 
into account that MTs participate also in immunoregulation 
[58-60], providing the protection against immune-mediated 
apoptosis [61] and participating in induction of local immune 
tolerance that is regulated by the controlled expression of 
hormones, cytokines and growth factors of maternal and fetal 
origin [4-8]. The hypothesis is supported also by findings that 
insufficient MT expression might induce tubal rupture, caused 
by elevation of CD56-positive cell numbers and increase in 
immune cell activity during the ectopic pregnancy in humans 
[61], as well as with observation that MTs in decidual cells 
ensure the proper coexistence between decidual cells and 
activated immune cells both in eutopic and ectopic pregnancy 
[9].  
Our data showing that treatment of pregnant mothers with 
PGM-Zn (originally derived from a Gram (+) bacteria) leads 
to an additional expression of MTs at the feto-placental 
interface (Fig. 1B) point to possible regulatory functions of 
MTs in pregnancy complicated by infection. In these 
conditions, it is likely that PGM-Zn stimulated the local 
transcription of MTs by STAT and ARE or by MTF-1 after 
activation of local immune response by PGM-Zn itself, or by 
its degradation products, such as disaccharide-pentapeptide 
moieties and zinc ions. The speculation needs to be proved, 
but we would like to emphasize that in the same experimental 
model we previously found that treatment with PGM-Zn led to 
increased expression of Toll like receptors 2 in extravillous 
and villous trophoblast cells and to enhanced recruitment of 
uterine NK cells to maternal-fetal interface [27]. Moreover, at 
the locations similar to that expressing MT I/II, we found a 
high expression of endoplasmic resident heat shock 
protein-glycoprotein 96 and its receptor-CD91, pointing to the 
interconnection of these two families of ancient cytoprotective 
proteins and their reactivity to the similar inducers that appear 
in the feto-placental unit.  
In agreement with current knowledge, our data also imply 
that MT I/II isoforms may be critically involved in the 
processes of organogenesis and fetal growth (Fig. 2A), as well 
as that placental MTs may contribute to adequate transport and 
storage of essential metals (Zn, Cu) required for fetal 
development and provide protection of fetus against heavy 
metal (Cd, Hg, Pb) toxicity and overloads. In this context, it 
was early described that in late gestation, MTs serve to bind 
Cu and Zn from the pre-existing pools of these metals, leading 
to accumulation of Zn in the fetal liver [11, 13, 62], as well as 
that MTs regulate free zinc ions bioavailability for function of 
multiple enzymes regulating cell growth, protein synthesis, 
hormone levels, growth factor metabolism and gene 
transcription, including the genes that regulate the 
inflammatory/immune response (reviewed by [20, 58-60, 63, 
64] Converting the proinflammatory and redox signals into 
zinc signals and acting as a free radical scavengers MTs 
regulate also the cellular energy state and the functional state 
of other apo-metalloproteins and provide a protection of 
macromolecules (e.g., proteins, lipids and DNA) against 
oxidative damage and proteolysis. High expression of MTs in 
fetal liver (Fig. 2 e-g) may be, therefore, related with the high 
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activities of Zn-dependent enzymes regulating DNA 
replication, as well as with the increased hepatic production of 
ROS by mitochondrial respiratory chain and cytochrome P450 
during the metabolism of fatty acids, cholesterol, steroids and 
bile acids. Our data, showing a prominent expression of MTs 
on hepatoblast and liver stromal cells also imply that they may 
contribute to mouse hematopoiesis, since in the fetal liver it is 
governed by “niche cells” surrounding the hematopoietic stem 
cells [65]. Similarly, our data showing high expression of MTs 
on epithelial and Paneth cells in intestine (Fig. 2 m-o) and on 
pancreatic acinar cells (Fig. 2 i-k) confirm that a network 
based on ZnT and ZIP proteins for transport and MTs for 
storage might contribute to the absorption of Zn in intestine 
[17] and in pancreas [66] or to the trapping and elimination of 
injurious Cu [67]. Moreover, since the MT expression at these 
places was additionally enhanced after the treatment of 
mothers with PGM-Zn we can speculate that Paneth cells in 
fetus were stimulated to secrete defensins, similarly as it was 
described after exposure to peptidoglycan or its degradation 
product muramyl dipeptide [68].  
Consistent with published evidence [62] herein we also show 
that MTs are expressed in the inner zone of the cortex of the 
fetal kidney (Fig. 2 r-t), as well as that treatment of mothers 
with PGM-Zn may enhance the MT immunoreactivity of this 
place (Fig. 2 u) pointing to a metal transport or excretory 
function of MTs at this location. The data imply that during 
pregnancy some PGM-Zn or its degradation products were 
transferred from mother to the fetus or that treatment with 
PGM-Zn has facilitated the placental transfer of other damages 
associated signals. In this context, it should be also taken into 
account that administration of PGM-Zn markedly affected the 
systemic immune response in the mother, inducing a high 
upregulation of gp96 in the liver and spleen, accumulation of 
NKT cells in the liver and augmentation of NK and NKT 
cells-mediated cytotoxicity [28]. Moreover, since we noticed 
that PGM-Zn might induce also the overexpression of MTs in 
maternal liver (not shown), there is a possibility that this was 
followed by hepatic retention of Zn and its reduced placental 
transfer to fetus. Noteworthy, it is likely that similar 
consequences may have the overproduction of placental MTs 
induced by PGM-Zn (Fig. 1B). since in different models it has 
been shown that overproduction of placental MTs, induced by 
highly toxic environmental pollutant, such as smoking, mercury 
vapor, cadmium, lead, arsen etc [35-40], might be associated to 
detrimental effects on fetal growth and development. In this 
conditions MTs assist in the trapping and elimination of 
injurious toxic metals, but as shown in smokers, this may 
induce also the retention of zinc and its lower transference to the 
fetus [69]. Moreover, recent evidence underline that zinc 
deficiency in utero may induce epigenetic alterations of mouse 
metallothionein-2 promoter region having MRE, that may be 
stored as an epigenetic memory until adulthood and cause a 
variety of disease states in children [26]  
Taken together, the data presented in this study show that 
MT expression in the placenta is important for the structural 
integrity and function of the placenta and fetal organogenesis 
in normal syngeneic pregnancy and emphasize that bacterial 
product PGM or Zn are powerful additional inducers of 
MT-I/II at maternal fetal interface and in fetal tissues. The 
findings suggest that placental MTs play an active role in the 
protection of decidualized endometrium and trophoblastic 
cells from oxidative and nitrative stress and from exogenous 
toxins as well as that MT/zinc network participate in the 
maternal-embryonic interchange of essential micronutrients 
and maintenance of zinc and copper homeostasis during the 
fetal development.  
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